Evidence map›Paper›PMID 28970239›Full record

ArticleThe Journal of experimental medicine2017

Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure.

Tania Nevers, Ane M Salvador, Francisco Velazquez, Njabulo Ngwenyama, Francisco J Carrillo-Salinas, Mark Aronovitz, Robert M Blanton, Pilar Alcaide

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 2 syntheses or guidelines pooled it, 215 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Translational biology of human cardiac fibrosis.Nature cardiovascular research · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tania NeversSackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA.
Ane M SalvadorSackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA.
Francisco VelazquezSackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA.
Njabulo NgwenyamaSackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA.
Francisco J Carrillo-SalinasSackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA.
Mark AronovitzMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.
Robert M BlantonMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.
Pilar AlcaideSackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA Pilar.Alcaide@tufts.edu.ORCID http://orcid.org/0000-0003-3013-3982
Tufts University · USTufts Medical Center · US

Funding

Training Program in Cardiovascular ResearchT32HL069770 · NHLBI · TUFTS MEDICAL CENTER · PI KARAS, RICHARD H · 2003 to 2013
$4.7M
IMMUNOLOGIC ASPECTS OF DISEASET32AI007077 · NIAID · TUFTS UNIVERSITY BOSTON · PI WORTIS, HENRY H. · 1985 to 2017
$3.5M
T Cell Mediated Immune Responses as a Regulator of Heart FailureR01HL123658 · NHLBI · TUFTS UNIVERSITY BOSTON · PI ALCAIDE ALONSO, MARIA PILAR · 2014 to 2018
$2.2M
Tufts Clinical and Translational Research InstituteKL2TR001063 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2013 to 2017
$2.1M
Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure ControlR01HL131831 · NHLBI · TUFTS MEDICAL CENTER · PI BLANTON, ROBERT MORRIS · 2016 to 2020
$2.1M
NCATS NIH HHS KL2 TR001063NHLBI NIH HHS R01 HL123658NHLBI NIH HHS R01 HL131831NHLBI NIH HHS T32 HL069770NIAID NIH HHS T32 AI007077
6 · The paper itself

Abstract

Despite emerging data indicating a role for T cells in profibrotic cardiac repair and healing after ischemia, little is known about whether T cells directly impact cardiac fibroblasts (CFBs) to promote cardiac fibrosis (CF) in nonischemic heart failure (HF). Recently, we reported increased T cell infiltration in the fibrotic myocardium of nonischemic HF patients, as well as the protection from CF and HF in TCR-α

Indexed as

AnimalsCell AdhesionFibroblastsFibrosisFlow CytometryHeart FailureIntegrin alpha4Interferon-gammaMice, Inbred C57BLMice, KnockoutMicroscopy, FluorescenceMyocardiumMyofibroblastsReceptors, Antigen, T-Cell, alpha-betaTh1 CellsTransforming Growth Factor betaIntegrin alpha4Interferon-gammaReceptors, Antigen, T-Cell, alpha-betaTransforming Growth Factor beta

Identifiers

PMID28970239
PMCPMC5679176
OpenAlexW2762433514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.